Skip to main content
. 2024 Jan 8;14:1299206. doi: 10.3389/fendo.2023.1299206

Table 1.

Basic information of the study subjects.

Control (n=18) T2DM (n=41) T2DM-MCI (n=36) p
Gender (Male) 7(38.9%) 27(65.9%) a 23(63.9%) a 0.016
Age (year) 53.78±12.82 56.93±9.22 59.78±7.68 0.088
Diabetes history (year) 9.90±7.41 10.04±6.86 0.932
years of education (year) 14.72±5.69 9.34±3.64 a 8.78±2.26 a <0.001
Systolic pressure (mmHg) 129.22±3.62 134.46±15.89 131.86±15.37 0.408
Diastolic blood pressure (mmHg) 77.33±3.91 85.78±10.94 a 83.36±8.82 a 0.007
BMI (kg/m2) 23.41±0.63 26.10±3.54 a 26.25±3.45 a 0.005
Blood glucose (mmol/l) 5.48±0.34 9.56±2.84 a 8.92±2.78 a <0.001
HbA1c(;%) 5.46±0.27 8.60±1.51 a 8.75±2.13 a <0.001
ALT(U/L) 22.00(13.50-27.00) 18.00(12.00-24.50) 18.00(12.00-26.00) 0.755
AST(U/L) 17.00(15.50-22.50) 18.00(15.00-23.00) 18.50(13.00-22.25) 0.619
Triglycerides (mmol/l) 1.13±0.58 1.70±1.64 1.56±0.97 0.277
Total cholesterol (mmol/l) 4.51±0.89 4.79±1.67 4.20±1.38 0.202
HDL-L (mmol/l) 1.31±0.31 1.23±0.55 1.17±0.38 0.575
LDL-C (mmol/l) 2.43±0.76 2.84±0.90 2.52±1.02 0.186
Urine (mmol/l) 5.61(4.83-5.98) 5.60(4.90-6.60) 5.80(4.90-6.90) 0.526
Creatinine (μmol/l) 70.78±7.45 72.52±16.68 75.41±23.64 0.661
Uric acid (μmol/l) 271.97±60.25 302.47±74.87 291.85±82.07 0.385
eGFR (ml/min/1.73m2) 91.90±13.64 95.39±19.00 89.77±21.40 0.447
a

versus control, p<0.05.

b

versus T2DM, p<0.05. Significant P values (<0.05) are indicated in bold.